PORTFOLIO - The BIR/DMC Radiology Reporting "Hands-On" HRCT

23rd September 2020  09:00 AM - 05:00 PM (GMT+01:00) Europe/London

Due to COVID-19 (Coronavirus),  this event has been postponed until further notice. All delegates currently booked on this event will be sent further details by email, once confirmed and available.

Please view our COVID-19 update page for further information. 



After a sell-out event in 2019, this event is back again in London for 2020!

Welcome to The BIR HRCT portfolio where you can build evidenced learning on HRCT and rise ahead of your colleagues! The registration fees for this event includes all components required to complete the portfolio. Find out more about the portfolio here or email us at conference@bir.org.uk

As part of the portfolio, you are required to attend The BIR/DMC Radiology Reporting "Hands-On" training series: HRCT in diffuse lung diseases on 23 September 2020 in London. This event will provide delegates with “Hands-On” experience of reviewing cases with experts in the field.

This event will provide delegates with “Hands-On” experience of reviewing cases with experts in the field.

View full event programme
 

Educational aims: 

  • To become familiar with common patterns of diffuse lung disease
  • To understand the relationships between radiological patterns and the likely pathological processes
  • To develop a systematic approach to HRCT interpretation in diffuse lung diseases
  • To become familiar with typical and atypical appearances of specified diffuse lung diseases

 

In each session, delegates will be asked to review case studies. This will be followed by an interpretation session with the experts, during which there will be dedicated time for delegates to pose questions and to interact with tutors.

 

The number of places will be limited so that delegates can experience a more personalised, interactive method of teaching. Early booking is therefore strongly advised.

 

The course will be run using iMacs to provide the best interactive experience for every delegate.

 

Past delegate feedback include:
 

As I found last year, this intensive course with it's associated package of learning resources has been exceptional. It is without doubt the best course I have ever attended and although quite expensive for a one day course it is worth every penny. The teaching is superb, the venue extremely convenient and the food etc also very good. I feel that I have earned my 10 CPD points!”

 

Excellent, thank you very much. I feel much more confident in approaching HRCT in my daily practice.

 

A really well planned/structured course, interesting cases. Great speakers.

 

Great educational value. Excellent range of cases covered. Hands on workshop brilliant.

 

View full event programme

 

Registration Fees

BIR Member Plan 1 £370

BIR Member Plan 2 £345

BIR Trainee member £345

BIR Retired/Student member £270

Non member £520

 

 

Photography disclaimer

The British Institute of Radiology may take photos at events. These images will be used by the BIR to share news about the event and to publicise upcoming events. Images may be used in press releases, printed publicity and published on the website and social media. They will be stored securely, and will be deleted after they are no longer needed for publicity purposes.

 

Please note, by registering for a BIR event you are giving consent for your photo to be used by the BIR for marketing and publicity purposes. If you would prefer not to be photographed, please email the BIR events team conference@bir.org.uk or speak to a member of staff on the day.

Venue

Speakers

Sponsors

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit https://www.siemens-healthineers.com/en-uk/